• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Lymphocytes in MS and EAE: More Than Just a CD4 World.

作者信息

Rangachari Manu, Kerfoot Steven M, Arbour Nathalie, Alvarez Jorge Ivan

机构信息

Department of Neurosciences, Centre de recherche du CHU de Québec - Université Laval, Quebec City, QC, Canada; Department of Molecular Medicine, Université Laval, Quebec City, QC, Canada.

Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University , London, ON , Canada.

出版信息

Front Immunol. 2017 Feb 13;8:133. doi: 10.3389/fimmu.2017.00133. eCollection 2017.

DOI:10.3389/fimmu.2017.00133
PMID:28243239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5303706/
Abstract
摘要

相似文献

1
Editorial: Lymphocytes in MS and EAE: More Than Just a CD4 World.社论：多发性硬化症和实验性自身免疫性脑脊髓炎中的淋巴细胞：不止是CD4的世界。
Front Immunol. 2017 Feb 13;8:133. doi: 10.3389/fimmu.2017.00133. eCollection 2017.
2
Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.阿片样生长因子和低剂量纳曲酮可抑制已建立的实验性自身免疫性脑脊髓炎（一种多发性硬化症模型）中CD4 + T淋巴细胞对中枢神经系统的浸润。
Exp Biol Med (Maywood). 2016 Jan;241(1):71-8. doi: 10.1177/1535370215596384. Epub 2015 Jul 22.
3
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.用不完全弗氏佐剂预先免疫神经抗原的小鼠 T 细胞耗竭脾细胞可预防实验性自身免疫性脑脊髓炎。
Immunol Lett. 2014 Jan-Feb;157(1-2):38-44. doi: 10.1016/j.imlet.2013.11.001. Epub 2013 Nov 9.
4
Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.自身免疫性脑脊髓炎的 CD4/T(H)1 以外的新观念。
Ann Anat. 2010 Aug 20;192(4):179-93. doi: 10.1016/j.aanat.2010.06.006. Epub 2010 Jul 15.
5
Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).用髓鞘碱性蛋白（MBP）进行表皮（EC）免疫可诱导TCRαβ⁺ CD4⁺ CD8⁺双阳性抑制细胞，这些细胞可预防实验性自身免疫性脑脊髓炎（EAE）。
J Autoimmun. 2007 Jun;28(4):208-15. doi: 10.1016/j.jaut.2007.02.017. Epub 2007 Apr 17.
6
Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.由CD8 + T细胞介导的实验性自身免疫性脑脊髓炎
Ann N Y Acad Sci. 2007 Apr;1103:157-66. doi: 10.1196/annals.1394.017. Epub 2007 Mar 21.
7
MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.主要组织相容性复合体（MHC）不匹配的混合嵌合体可增强胸腺调节性T细胞的产生，并预防小鼠实验性自身免疫性脑脊髓炎（EAE）的复发。
Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15994-9. doi: 10.1073/pnas.1521157112. Epub 2015 Dec 8.
8
MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.MOG 细胞外结构域 (p1-125) 可引发小鼠中枢神经系统中 CXCR3+ CD4+ Th1 细胞的频率升高，并导致更严重的 EAE 发生率增加。
Mult Scler. 2014 Sep;20(10):1312-21. doi: 10.1177/1352458514524086. Epub 2014 Feb 19.
9
Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.
J Int Med Res. 2014 Apr;42(2):530-41. doi: 10.1177/0300060513505267. Epub 2014 Feb 4.
10
Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.大鼠免疫系统的年龄相关变化：从实验性自身免疫性脑脊髓炎中汲取的经验教训。
Exp Gerontol. 2014 Oct;58:179-97. doi: 10.1016/j.exger.2014.08.005. Epub 2014 Aug 13.

引用本文的文献

1
The Emerging Role of Immunoglobulins and Complement in the Stimulation of Neuronal Activity and Repair: Not as Simple as We Thought.免疫球蛋白和补体在刺激神经元活动和修复中的新作用：并不像我们想象的那么简单。
Biomolecules. 2024 Oct 18;14(10):1323. doi: 10.3390/biom14101323.
2
The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations.不同巨噬细胞亚群在 MS 发病机制中的作用以及不同治疗药物对这些群体的影响。
Front Immunol. 2021 Aug 20;12:667705. doi: 10.3389/fimmu.2021.667705. eCollection 2021.
3
Triggering Innate Immune Receptors as New Therapies in Alzheimer's Disease and Multiple Sclerosis.触发先天免疫受体作为阿尔茨海默病和多发性硬化症的新疗法。
Cells. 2021 Aug 22;10(8):2164. doi: 10.3390/cells10082164.
4
Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by Polysaccharide A.探索肠道-脑轴控制中枢神经系统炎症性脱髓鞘：多糖 A 的免疫调节作用。
Front Immunol. 2021 May 5;12:662807. doi: 10.3389/fimmu.2021.662807. eCollection 2021.
5
Beneficial Roles of Microglia and Growth Factors in MS, a Brief Review.小胶质细胞和生长因子在多发性硬化症中的有益作用：简要综述
Front Cell Neurosci. 2020 Sep 23;14:284. doi: 10.3389/fncel.2020.00284. eCollection 2020.
6
The Helminth Parasite Attenuates EAE in an IL-4Rα-Dependent Manner.寄生虫能以依赖于白介素-4 受体α的方式减弱实验性自身免疫性脑脊髓炎。
Front Immunol. 2020 Sep 29;11:1830. doi: 10.3389/fimmu.2020.01830. eCollection 2020.
7
Imaging the Neuroimmune Dynamics Across Space and Time.对神经免疫在空间和时间上的动态变化进行成像。
Front Neurosci. 2020 Sep 23;14:903. doi: 10.3389/fnins.2020.00903. eCollection 2020.
8
Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis.实验性自身免疫性脑脊髓炎中髓鞘少突胶质细胞糖蛋白（MOG）35-55 特异性 CD8+T 细胞的特征。
Chin Med J (Engl). 2019 Dec 20;132(24):2934-2940. doi: 10.1097/CM9.0000000000000551.
9
Microglial priming of antigen presentation and adaptive stimulation in Alzheimer's disease.阿尔茨海默病中抗原呈递和适应性刺激的小胶质细胞预激活。
Cell Mol Life Sci. 2019 Oct;76(19):3681-3694. doi: 10.1007/s00018-019-03132-2. Epub 2019 May 15.
10
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.先天、先天样和适应性淋巴细胞在 MS 和 EAE 发病机制中的作用。
Cell Mol Immunol. 2019 Jun;16(6):531-539. doi: 10.1038/s41423-019-0221-5. Epub 2019 Mar 15.

本文引用的文献

1
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives.原发性进行性多发性硬化症：当前的治疗策略与未来展望。
Expert Rev Neurother. 2017 Apr;17(4):393-406. doi: 10.1080/14737175.2017.1257385. Epub 2016 Nov 15.
2
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal.那他珠单抗停药后致死性复发型多发性硬化症活动的免疫和病理特征
Mult Scler. 2017 Jan;23(1):72-81. doi: 10.1177/1352458516641775. Epub 2016 Jul 11.
3
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.进展性多发性硬化症的治疗进展与未来前景。
Neurotherapeutics. 2016 Jan;13(1):58-69. doi: 10.1007/s13311-015-0409-z.
4
Biomarkers in multiple sclerosis.多发性硬化症的生物标志物。
Clin Immunol. 2015 Nov;161(1):51-8. doi: 10.1016/j.clim.2015.06.015. Epub 2015 Jul 2.
5
Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation.黑色素瘤细胞黏附分子阳性 CD8 T 淋巴细胞介导中枢神经系统炎症。
Ann Neurol. 2015 Jul;78(1):39-53. doi: 10.1002/ana.24415. Epub 2015 May 20.
6
Role of the innate and adaptive immune responses in the course of multiple sclerosis.固有免疫和适应性免疫应答在多发性硬化中的作用。
Lancet Neurol. 2015 Apr;14(4):406-19. doi: 10.1016/S1474-4422(14)70305-9.
7
Pathology of multiple sclerosis and related inflammatory demyelinating diseases.多发性硬化症及相关炎性脱髓鞘疾病的病理学
Handb Clin Neurol. 2014;122:15-58. doi: 10.1016/B978-0-444-52001-2.00002-9.
8
Environmental factors in multiple sclerosis.多发性硬化的环境因素。
Expert Rev Neurother. 2013 Dec;13(12 Suppl):3-9. doi: 10.1586/14737175.2013.865866.
9
Revealing the genetic basis of multiple sclerosis: are we there yet?揭示多发性硬化症的遗传基础：我们做到了吗？
Curr Opin Genet Dev. 2011 Jun;21(3):317-24. doi: 10.1016/j.gde.2010.12.006. Epub 2011 Jan 17.
10
Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity.在多发性硬化症的阿仑单抗治疗后，残疾的改善与神经保护性自身免疫有关。
Brain. 2010 Aug;133(Pt 8):2232-47. doi: 10.1093/brain/awq176. Epub 2010 Jul 21.